Fluorescent protein tagging promotes phase separation and alters the aggregation pathway of huntingtin exon-1
Journal of Biological Chemistry · 2024-01 · 300 (1) · 105585
DOI: 10.1016/j.jbc.2023.105585 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Biological Chemistry, 2024-01. Verfasst von Nitin K Pandey und 5 weiteren Autor:innen. Beteiligte Einrichtung: Physiology and Neuroscience, Zilkha Neurogenetic Institute, Keck School of Medicine, University of Southern California, Los Angeles, California, USA. Hauptthemen laut MEDLINE: Artifacts, Exons, Huntingtin Protein, Huntington Disease. Die Arbeit wurde bisher 46-mal zitiert (Crossref) und nennt 63 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NINDS NIH HHS, National Institutes of Health.
Abstract (Originalsprache)
Fluorescent protein tags are convenient tools for tracking the aggregation states of amyloidogenic or phase separating proteins, but the effect of the tags is often not well understood. Here, we investigated the impact of a C-terminal red fluorescent protein (RFP) tag on the phase separation of huntingtin exon-1 (Httex1), an N-terminal portion of the huntingtin protein that aggregates in Huntington's disease. We found that the RFP-tagged Httex1 rapidly formed micron-sized, phase separated states in the presence of a crowding agent. The formed structures had a rounded appearance and were highly dynamic according to electron paramagnetic resonance and fluorescence recovery after photobleaching, suggesting that the phase separated state was largely liquid in nature. Remarkably, the untagged protein did not undergo any detectable liquid condensate formation under the same conditions. In addition to strongly promoting liquid-liquid phase separation, the RFP tag also facilitated fibril formation, as the tag-dependent liquid condensates rapidly underwent a liquid-to-solid transition. The rate of fibril formation under these conditions was significantly faster than that of the untagged protein. When expressed in cells, the RFP-tagged Httex1 formed larger aggregates with different antibody staining patterns compared to untagged Httex1. Collectively, these data reveal that the addition of a fluorescent protein tag significantly impacts liquid and solid phase separations of Httex1 in vitro and leads to altered aggregation in cells. Considering that the tagged Httex1 is commonly used to study the mechanisms of Httex1 misfolding and toxicity, our findings highlight the importance to validate the conclusions with untagged protein.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Physiology and Neuroscience, Zilkha Neurogenetic Institute, Keck School of Medicine, University of Southern California, Los Angeles, California, USA.
- Physiology and Neuroscience, Zilkha Neurogenetic Institute, Keck School of Medicine, University of Southern California, Los Angeles, California, USA; Biochemistry and Molecular Medicine, Zilkha Neurogenetic Institute, K…
Förderung
- NINDS NIH HHS
- National Institutes of Health
Zitieren
APA
Pandey, N. K., Varkey, J., Ajayan, A., George, G., Chen, J., & Langen, R. (2024). Fluorescent protein tagging promotes phase separation and alters the aggregation pathway of huntingtin exon-1. Journal of Biological Chemistry, 300(1), 105585. https://doi.org/10.1016/j.jbc.2023.105585
Vancouver
Pandey NK, Varkey J, Ajayan A, George G, Chen J, Langen R. Fluorescent protein tagging promotes phase separation and alters the aggregation pathway of huntingtin exon-1. Journal of Biological Chemistry. 2024;300(1):105585. doi:10.1016/j.jbc.2023.105585
BibTeX
@article{Pandey2024,
author = {Pandey, Nitin K and Varkey, Jobin and Ajayan, Anakha and George, Gincy and Chen, Jeannie and Langen, Ralf},
title = {Fluorescent protein tagging promotes phase separation and alters the aggregation pathway of huntingtin exon-1},
journal = {Journal of Biological Chemistry},
year = {2024},
volume = {300},
number = {1},
pages = {105585},
doi = {10.1016/j.jbc.2023.105585}
}
EUVIMED